|
Mechanism30S subunit inhibitors [+2] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date23 Sep 2010 |
100 Clinical Results associated with Neochem Pharmaceutical Laboratories Ltd.
0 Patents (Medical) associated with Neochem Pharmaceutical Laboratories Ltd.
100 Deals associated with Neochem Pharmaceutical Laboratories Ltd.
100 Translational Medicine associated with Neochem Pharmaceutical Laboratories Ltd.